|
- This Is Precision in Practice - iRhythm Tech
Discover the iRhythm monitoring service, featuring Zio® ECG monitors Our monitoring solutions capture heartbeat data to help doctors detect cardiac arrhythmias
- iRhythm Technologies, Inc. - iRhythm Launches Next Generation Zio . . .
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information
- iRhythm | Stanford Mussallem Center for Biodesign | Stanford Medicine
What is the need iRhythm seeks to address? We wanted to find a better way to diagnose suspected heart rhythm problems, or arrhythmias, in non-hospitalized patients
- iRhythm Creates a New Basis for Discretionary Denial
The recent decision in iRhythm Technologies v Welch Allyn Inc , IPR2025-00377, et al (Director Review: June 6, 2025) establishes a new and independent basis for discretionary denial: petitioner
- Q A with iRhythm Technologies: The importance of arrhythmia detection
iRhythm is a leading digital healthcare company that creates trusted solutions that detect, predict, and prevent disease iRhythm combines wearable biosensors and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information
- Behind the Design: How iRhythm Built Its New Zio Monitor - MDDI Online
iRhythm Technologies recently launched its next-generation Zio monitor and enhanced Zio long-term continuous monitoring service in the United States The San Francisco, CA-based company touts an improved form factor with the new wearable heart monitoring device, which is 23% thinner, 62% lighter, and 72% smaller compared to previous generations
- Cardiac Monitoring Solutions Designed for Patients | iRhythm
Zio® ECG monitors are designed for comfort and ease of use and to continuously record your heartbeat as you go about your daily life Learn more about iRhythm's cardiac monitoring solutions
- iRhythm, fighting Boston Scientific for market share, shows cardiac . . .
iRhythm Technologies presented an analysis of Medicare claims data showing its Zio XT outperforms other ambulatory cardiac monitors, boosting the company’s bid to win market share The U S market is less than 30% penetrated, according to analysts at William Blair
|
|
|